The article was devoted to functional dyspepsia, which is defined as chronic or repeated complaints in the upper part of the abdomen (e.g. fullness after eating, early satiety, pain or burning in the epigastrium) without demonstrable organic disease during routine examinations.[1][3] Its high incidence in the population and significant impact on patients' quality of life are described.[1] The authors distinguish the main clinical subtypes of the disease according to the predominant symptoms (especially postprandial distress syndrome and epigastric pain syndrome) and emphasize that the diagnosis is based on the so-called Roman criteria.[1][3] The article states that it is important to rule out warning signs (e.g. weight loss, vomiting, bleeding, anemia) during diagnosis and to perform an endoscopic examination in high-risk patients.[1] Several groups of drugs are indicated in the treatment, especially proton pump inhibitors, prokinetics and drugs affecting the nervous system of the gut and brain (eg some antidepressants), as well as eradication of Helicobacter pylori, if present.[1][3] The text emphasizes that the response to treatment is variable and a long-term and combined strategy including non-pharmacological measures (diet modification, stress reduction) is often required.[1] The authors state that functional dyspepsia is a chronic disease with frequent recurrences of complaints and that the goal of management is to reduce the intensity of symptoms and improve the daily functioning of the patient.[1][3]